Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2008-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.IJROBP.2007.07.2363PMID 17931794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 GY versus 78 Gy.

  2007cited by this paper
• Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

  2005cited by this paper
• Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.

  2005cited by this paper
• Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy.

  2005cited by this paper
• Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

  2005cited by this paper
• Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

  2005cited by this paper
• Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.

  2004cited by this paper
• Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.

  2004cited by this paper
• Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).

  2004cited by this paper
• Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.

  2004cited by this paper
• CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

  2003cited by this paper
• Hazards of dose escalation in prostate cancer radiotherapy.

  2003cited by this paper
• Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.

  2003cited by this paper
• Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicity.

  2003cited by this paper
• Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer.

  2003cited by this paper
• Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.

  2002cited by this paper
• Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.

  2002cited by this paper
• A model to simulate day-to-day variations in rectum shape.

  2002cited by this paper
• Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

  2001cited by this paper
• Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial.

  2000cited by this paper
• [Prostatic carcinoma: problems in the interpretation of rectal dose-volume histograms].

  2000cited by this paper
• Prostatakarzinom: Zur Problematik bei der Interpretation rektaler Dosis-Volumen-Histogramme

  2000cited by this paper
• Dose-wall histograms and normalized dose-surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy.

  1999cited by this paper
• Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.

  1998cited by this paper
• Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms.

  1996cited by this paper
• Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate.

  1995cited by this paper
• EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale.

  1995cited by this paper
• Late effects toxicity scoring: the SOMA scale

  1995cited by this paper
• Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer.

  1995cited by this paper
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

  1995cited by this paper
• ICRU Report 50—Prescribing, Recording and Reporting Photon Beam Therapy

  1994cited by this paper
• A verification procedure to improve patient set-up accuracy using portal images.

  1993cited by this paper

• Radiation-induced skin injury: a review of pathophysiology, assessment, management, and re-irradiation protocols

  2026cites this paper
• Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity

  2025cites this paper
• Assessment of radiation dermatitis in locally advanced head and neck cancer patients treated with concurrent chemoradiotherapy using LENT-SOMA scale: hematological indicators-based nomogram model

  2025cites this paper
• Predictive Factors for Gastrointestinal and Genitourinary Toxicities in Prostate Cancer External Beam Radiotherapy: A Scoping Review

  2025cites this paper
• Uncertainties in outcome modelling in radiation oncology

  2025cites this paper
• Clinical and epidemiological observations on individual radiation sensitivity and susceptibility

  2020cites this paper
• Hydrogel Spacer Reduces Rectal Dose during Proton Therapy for Prostate Cancer: A Dosimetric Analysis.

  2019cites this paper
• Rectum and lung normal tissue complication probability: a retrospective analysis depending on different numbers of fractions and different dose-limits

  2019cites this paper
• Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients

  2018cites this paper
• Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose – volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?

  2017cites this paper
• Do protons have a role in the treatment of locally advanced NSCLC with radiotherapy?

  2017cites this paper
• Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives

  2017cites this paper
• Moderate dose escalation with volumetric modulated arc therapy improves outcome in rectal cancer

  2017cites this paper
• Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?

  2017cites this paper
• Analyzing the Usage of Standards in Radiation Therapy Clinical Studies.

  2017cites this paper
• Analyzing the usage of standards in radiation therapy clinical studies

  2017cites this paper
• 78Gy with Fiducial Marker Image‐Guided Radiotherapy in Prostate Cancer: Single Center Analysis of 301 Patients

  2017cites this paper
• Long term toxicity after radiotherapy for prostate cancer: generation of multivariable prediction models

  2017cites this paper
• Does body mass index or subcutaneous adipose tissue thickness affect interfraction prostate motion in patients receiving radical prostate radiotherapy?

  2016cites this paper
• Gastro-intestinal dose-volume effects in the context of dose-volume constrained prostate radiotherapy : an analysis of data from the RADAR prostate radiotherapy trial

  2016cites this paper
• Amelioration and assessment of gastrointestinal acute toxicity and late effects of pelvic radiotherapy

  2016cites this paper
• Predictive parameters of symptomatic haematochezia following 5-fraction gantry-based SABR in prostate cancer.

  2016cites this paper
• Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer.

  2016cites this paper
• Outcome modeling techniques for prostate cancer radiotherapy: Data, models, and validation.

  2016cites this paper
• Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients.

  2016cites this paper
• Recent advancements in toxicity prediction following prostate cancer radiotherapy

  2015cites this paper
• Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: analysis of data from the RADAR prostate radiation therapy trial.

  2015cites this paper
• Optimising the management of gastrointestinal symptoms following pelvic radiotherapy.

  2014cites this paper
• Derivation and representation of dose-volume response from large clinical trial data sets: an example from the RADAR prostate radiotherapy trial

  2014cites this paper
• The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients.

  2014cites this paper
• Radiation Induced Rectal Toxicity

  2014cites this paper
• Two non-parametric methods for derivation of constraints from radiotherapy dose–histogram data

  2014cites this paper
• Diet and Gastrointestinal Symptoms in Patients with Prostate Cancer Treated with Radiotherapy

  2014cites this paper
• Comparison of effect of rectal volume delineation methods on dose constraint endpoints in the treatment of prostate cancer with intensity-modulated radiation therapy

  2013cites this paper
• Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy

  2013cites this paper
• Predictive models of toxicity in intensity modulated radiotherapy

  2013cites this paper
• oxicité rectale de la radiothérapie : signes cliniques , physiopathologie et prise n charge adiation-induced proctitis : Symptoms , pathophysiology and treatment

  2012cites this paper
• Cross Practitioner Inter-rater Variability: Grading of Adverse Skin Reactions after Radiation Therapy

  2012influential citation
• Toxicité rectale de la radiothérapie : signes cliniques, physiopathologie et prise en charge

  2012cites this paper
• Biomarkers of normal tissue toxicity after pelvic radiotherapy

  2012cites this paper
• The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.

  2012cites this paper
• [Radiation-induced proctitis: symptoms, pathophysiology and treatment].

  2012cites this paper
• Early radiation-induced mucosal changes evaluated by proctoscopy: predictive role of dosimetric parameters.

  2012cites this paper
• Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.

  2012cites this paper
• Consolidating risk estimates for radiation-induced complications in individual patient: late rectal toxicity.

  2012cites this paper
• Modeling late rectal toxicities based on a parameterized representation of the 3D dose distribution

  2011cites this paper
• Parameterizing the dose distribution for NTCP modeling 2 1

  2011cites this paper
• Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.

  2011cites this paper
• Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre

  2011cites this paper
• Efficacy of data capture for patient-reported toxicity following radiotherapy for prostate or cervical cancer.

  2010cites this paper
• Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)

  2010cites this paper
• [Normal tissue tolerance to external beam radiation therapy: rectum].

  2010cites this paper
• Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy.

  2010cites this paper
• Dosimetric comparison of three-dimensional conformal radiotherapy in salvage radiotherapy for PSA relapse after radical prostatectomy.

  2010cites this paper
• A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.

  2010cites this paper
• Measurement tools for gastrointestinal symptoms in radiation oncology

  2009cites this paper
• Current world literature. Pain: cancer.

  2009cites this paper
• Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: A combination of conformal dynamic-arc and five-static field technique.

  2009cites this paper
• Predictive factors of gastroduodenal toxicity in cirrhotic patients after three-dimensional conformal radiotherapy for hepatocellular carcinoma.

  2009cites this paper
• Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.

  2009cites this paper
• Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.

  2009cites this paper
• Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397)

  2009cites this paper
• Predictive models of toxicity in external radiotherapy

  2009cites this paper
• Dose-volume effects for normal tissues in external radiotherapy: pelvis.

  2009cites this paper
• Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding

  2009cites this paper
• Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991.

  2009cites this paper
• Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study.

  2009cites this paper
• Longitudinal Cytokine Expression during IMRT for Prostate Cancer and Acute Treatment Toxicity

  2009cites this paper
• Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: planning data and toxicity results of a Phase I-II study.

  2008cites this paper
• Radiation therapy in pituitary adenomas

  2008cites this paper